Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Bill gives generic drug makers ability to alter safety information

Filed April 19th, 2012 Laurie

Several Democrats in Congress are set to introduce legislation allowing generic prescription drug makers to update their own safety labels when they find studies suggesting they carry certain risks of serious side effects.

Currently, the makers of generic prescription drugs are barred from updating the safety labels on their drugs, hamstrung by the makers of the brand-name version, which must apply to the Food and Drug Administration to do so. Even if a generic drug maker is well aware of the dangers of their drug, they are unable to force any action and compel the maker of the name brand drug to change its label.

This limitation makes them almost indefensible if a person taking the drug suffers an unexpected side effect, one not mentioned on any safety information.

According to ModernHealthcare.com, several Democrats in Congress have drafted the Patient Safety and Generic Labeling Improvement Act that would allow generic drug makers to alter safety labels through the same process as name-brand makers. The legislation is lead by Reps. Chris Van Hollen (D-Md.), and Bruce Braley (D-Iowa) in the House, and Sens. Patrick Leahy (D-Vt.), Jeff Bingaman (D-N.M.), Richard Blumenthal (D-Conn.), Sherrod Brown (D-Ohio), Christopher Coons (D-Del.), Al Franken (D-Minn.), and Sheldon Whitehouse (D-R.I.).

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!